Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease

Fibroblast growth factor-23 (FGF23) is an established biomarker of adverse outcomes in patients with chronic kidney disease (CKD). Several cross-sectional studies have suggested a possible association between FGF23 and anemia in these patients. In this large-scale prospective cohort study, we invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Ki Heon, Kim, Hyoungnae, An, Seong Yeong, Lee, Misol, Cha, Min-Uk, Park, Jung Tak, Yoo, Tae-Hyun, Lee, Kyu-Beck, Kim, Yeong-Hoon, Sung, Su-Ah, Lee, Joongyub, Kang, Shin-Wook, Choi, Kyu Hun, Ahn, Curie, Han, Seung Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940871/
https://www.ncbi.nlm.nih.gov/pubmed/29740119
http://dx.doi.org/10.1038/s41598-018-25439-z

Ejemplares similares

Ejemplares similares